Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 3 November 2009, doi:10.1136/bmj.b4556
Cite this as: BMJ 2009;339:b4556
Clare Dyer
1 BMJ
| The first 150 words of the full text of this article appear below. |
The former research dean of Sheffield Universitys medical school was accused of dishonesty at a General Medical Council hearing on 2 November for allowing a journal to publish a false claim that he had seen all the data in a research study of which he was the lead author.
Richard Eastell, who heads the bone research unit at Sheffield University, is at the centre of a research ethics case that saw the other main investigator, Aubrey Blumsohn, who raised questions over the data, take a financial settlement to leave his job at the university.
Dr Blumsohn says that he and Professor Eastell both asked Procter & Gamble, which was funding the study into its osteoarthritis drug risedronate (Actonel), for access to the full data but were refused. The university had been asked to carry out measurements on blood and urine samples that had been taken during clinical trials in the
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?